Enzyme inhibitors
Showing 1 - 25 of 6,800
Therapeutic Drug Use for CKD Patients
Active, not recruiting
- Chronic Kidney Disease
- angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
-
Jinan, Shandong, ChinaXiao Li,MD
Apr 18, 2023
Angiotensin Converting Enzyme Inhibitors and Angiotensin
Not yet recruiting
- COVID-19 Pneumonia
- Covid_19
- (no location specified)
Jun 5, 2022
Bradykinin-degradating Enzymes Activities in
Recruiting
- Angio-Oedema Caused by Angiotensin-Converting-Enzyme Inhibitor
- Assay of Bradykinin-degradating enzymes.
-
Grenoble, FranceChu Grenoble Alpes
Jan 14, 2022
Vascular Access Complication Trial in Rawalpindi (Losartan Potassium, multi-vitamins)
Recruiting
- Vascular Access Complication
- Losartan Potassium
- multi-vitamins
-
Rawalpindi, Punjab, PakistanAnas Bin Saif
Nov 22, 2021
Surgery, Angiotensin Hypertension, Perioperative Complication Trial in Netherlands (drug, diagnostic test, behavioral)
Recruiting
- Surgery
- +2 more
- Perioperative withdrawal of angiotensin converting enzyme inhibitors and angiotenin receptor blockers
- +4 more
-
Amsterdam, Netherlands
- +6 more
Jan 6, 2022
AML, Acute Myeloid Leukemia Trial in Charlottesville (Cardioprotection)
Recruiting
- AML
- Acute Myeloid Leukemia
-
Charlottesville, VirginiaUniversity of Virginia
Jul 2, 2022
Chronic Kidney Disease, Blood Pressure, Angiotensin-converting Enzyme Inhibitor Trial in San Francisco (Continuation of ACEi
Active, not recruiting
- Chronic Kidney Disease
- +3 more
- Continuation of ACEi and/or ARBs
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 4, 2021
Male Erectile Disorder, Prostate Cancer, Radiation Toxicity Trial in Winston-Salem (Placebo, Oral L-Arginine)
Completed
- Male Erectile Disorder
- +2 more
- Placebo
- Oral L-Arginine
-
Winston-Salem, North CarolinaW F Baptist Health
Sep 7, 2021
STEMI - ST Elevation Myocardial Infarction, Left Ventricular Systolic Dysfunction Trial (Dapagliflozin 10Mg Tab, Placebo)
Not yet recruiting
- STEMI - ST Elevation Myocardial Infarction
- Left Ventricular Systolic Dysfunction
- Dapagliflozin 10Mg Tab
- Placebo
- (no location specified)
Sep 6, 2021
Angiotensin Converting Enzyme Inhibitors and Incident
Unknown status
- Covid-19, Coronavirus, Angiotensin Converting Enzyme Inhibitors, Influenza, Electronic Health Records, Epidemiology, Comorbidity, Incidence, United Kingdom
- ACE inhibitor
- (no location specified)
Nov 11, 2020
Cutaneous Melanoma Trial in Paris (Blood sample, Cutaneous melanoma biopsy)
Recruiting
- Cutaneous Melanoma
- Blood sample
- Cutaneous melanoma biopsy
-
Paris, Ile De France, FranceDermatology department
Oct 24, 2022
NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in Worldwide (Furmonertinib)
Recruiting
- Non-Small Cell Lung Cancer
- +14 more
-
Glendale, California
- +12 more
Feb 2, 2023
Chagas Cardiomyopathy Trial in São Paulo (Sacubitril / Valsartan Oral Tablet [Entresto], Enalapril)
Recruiting
- Chagas Cardiomyopathy
- Sacubitril / Valsartan Oral Tablet [Entresto]
- Enalapril
-
São Paulo, BrazilHeart Institute (Incor) University of Sao Paulo
May 6, 2021
Transcatheter Aortic Valve Replacemen, Angiotensin-Converting Enzyme Inhibitors Trial in Valladolid (Ramipril)
Active, not recruiting
- Transcatheter Aortic Valve Replacemen
- Angiotensin-Converting Enzyme Inhibitors
-
Valladolid, SpainHospital Clínico Universitario de Valladolid
Sep 23, 2021
Exercise, Angiotensin-Converting Enzyme Inhibitors Trial in Copenhagen (Enalapril, Placebo)
Completed
- Exercise
- Angiotensin-Converting Enzyme Inhibitors
- Enalapril
- Placebo
-
Copenhagen, DenmarkDepartment of Nutrition, Exercise and Sports
Nov 3, 2020
Human Immunodeficiency Virus Type 1 (HIV-1) Infection Trial (Vesatolimod, Cobicistat, Voriconazole)
Not yet recruiting
- Human Immunodeficiency Virus Type 1 (HIV-1) Infection
- Vesatolimod
- +3 more
- (no location specified)
Jul 11, 2022
Hematoma, Subdural, Chronic Trial (Perindopril, Placebo)
Hypertension, COVID-19 Trial in Kiev (Angiotensin converting enzyme inhibitor, Angiotensin Receptor Blockers, Direct renin
Completed
- Hypertension
- COVID-19
- Angiotensin converting enzyme inhibitor
- +2 more
-
Kiev, Please Select, UkraineMedical Practice Prof D.Ivanov
Feb 16, 2022
Pathophysiologic Hemodynamics After Primary Unilateral Total Hip
Recruiting
- Orthostatic Intolerance
- Orthostatic Hypotension
- Mobilisation procedure
-
Copenhagen, DenmarkHvidovre University Hospital
Apr 8, 2021
Kidney Disease Trial in United States (Bremelanotide, RAAS inhibition therapy)
Recruiting
- Kidney Disease
- Bremelanotide
- RAAS inhibition therapy
-
Chula Vista, California
- +5 more
Jan 23, 2023
Hydroxychloroquine, Antimalarials, Enzyme Inhibitors Trial in Mexico City (Hydroxychloroquine Sulfate, Bromhexine 8 MG)
Enrolling by invitation
- Hydroxychloroquine
- +3 more
- Hydroxychloroquine Sulfate
- Bromhexine 8 MG
-
Mexico City, Cdmx, MexicoNational Institute of Rehabilitation, Luis Guillermo Ibarra Ibar
Jun 26, 2021
Coronavirus Disease 2019 Patients Receiving Receiving
Completed
- COVID-19
- Angiotensin-Converting Enzyme Inhibitors (ACE-I) and Angiotensin II Receptor Blockers (ARB)
-
Riyadh, Saudi ArabiaKing Faisal Specialist Hospital & Research Centre
Aug 1, 2020
Diabetes, Cardiovascular Diseases Trial in Singapore (Renin-angiotensin-aldosterone system inhibitors, Beta blocker, SGLT2
Recruiting
- Diabetes Mellitus
- Cardiovascular Diseases
- Renin-angiotensin-aldosterone system inhibitors
- +2 more
-
Singapore, SingaporeSingapore General Hospital (SGH)
Apr 28, 2021
COVID-19, Cardiovascular Diseases Trial in Brazil, Canada, Mexico (Angiotensin converting enzyme inhibitor, Angiotensin II
Recruiting
- COVID-19
- Cardiovascular Diseases
- Angiotensin converting enzyme inhibitor
- Angiotensin II Receptor Blockers
-
Maceio, Alagoas, Brazil
- +30 more
Jan 13, 2023
NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in United States (furmonertinib 240 mg, furmonertinib 160 mg, platinum-based chemo)
Recruiting
- Non-Small Cell Lung Cancer
- +13 more
- furmonertinib 240 mg
- +2 more
-
Yuma, Arizona
- +37 more
Dec 14, 2022